Vector Therapeutics is Biotechnology in United States that focus on therapeutic drugs business. Founded in 2016. They cover business area such as manufacturer, therapeutic drug, hypoxia, human, oxygen, tissue, development, commercialization, class, catastrophic brain damage, fromhypoxic condition, brain stroke, Cardiac Cerebrovascular Accidents, (CVA, enable patient, avail variety, wound healing application.
2016
( 8 years old in 2024 )
Therapeutic Drugs
-
233 Needham Street
Suite 300
Newton, MA 02464
United States
Private
manufacturertherapeutic drughypoxiahumanoxygentissuedevelopmentcommercializationclasscatastrophic brain damagefromhypoxic conditionbrain strokeCardiac Cerebrovascular Accidents(CVAenable patientavail varietywound healing application
* We use standard office opening hours in near Vector Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Vector Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Vector Therapeutics business is focusing on Therapeutic Drugs.
Vector Therapeutics headquarter office and corporate office address is located in 233 Needham Street Suite 300 Newton, MA 02464 United States.
Vector Therapeutics was founded in United States.
In 2024, Vector Therapeutics is currently focus on therapeutic drugs sector.
Above is snippet of Google Trends for "therapeutic drugs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Vector Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
